Diabetes Care Devices Market Updates

Diabetes Care Devices Market size was valued at USD 29.02 Billion in 2023 and is poised to grow from USD 31.54 Billion in 2024 to USD 61.49 Billion by 2032, growing at a CAGR of 8.7% during the forecast period (2025-2032).

Global Diabetes Care Devices Market is highly fragmented with the presence of several small and large market players operating all over the world. Major companies of the market are implementing several business strategies such as new product launches, acquisition & mergers, collaboration, and partnerships for the expansion of their geographical presence and their product portfolio. 'F. Hoffman-La Roche Ltd. ', 'Abbott ', 'Ascensia Diabetes Care Holdings AG ', 'Dexcom, Inc. ', 'Medtronic PLC ', 'B. Braun Melsungen AG ', 'Becton, Dickinson and Company ', 'Arkray, Inc. ', 'Sanofi ', 'Novo Nordisk A/S ', 'Terumo Corporation ', 'Ypsomed ', 'Sinocare, Inc. ', 'AgaMatrix Holdings LLC ', 'SD Biosensor, Inc. ', 'Microgene Diagnostic Systems Pvt. Ltd. ', 'Dr. Morepen ', 'Bionime Corporation ', 'Rossmax International Ltd.'

Rising adoption of insulin-delivery devices and the rising prevalence of diabetes are driving the market growth. An increasing number of people are being diagnosed with Type-2 diabetes due to a sedentary lifestyle and unhealthy choices. According to the International Diabetes Federation (IDF), around 537 million adults have diabetes. This can lead to the development of various chronic diseases in the human body. Therefore, the need to regulate and control diabetes is important.

Increased adoption of test strips and self-monitoring blood glucose meters and rising demand for continuous glucose monitoring with increasing awareness of the disease in developing countries are major reasons leading to the growth of the diabetes monitoring devices segment. WHO indicates that more than 60% of the worldwide population isn't adequately dynamic. The World Wellbeing Organization expresses that active work is one of the life-supporting elements and the danger of type 2 diabetes ascends with expanding body weight at all ages. People are becoming more conscious about their health and wellbeing, therefore players can find lucrative growth opportunities in the global market.

Due to its well-established healthcare industry, North America is expected to continue to dominate the global diabetes care devices market share. According to projections, the U.S. market will rise due to factors such as the rising prevalence of obesity, the high cost of treatment, technological advancements, and new product introductions.